elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27851852-74CB4FAF-6E69-4762-A30E-3E4547EBD503
Q27851852-74CB4FAF-6E69-4762-A30E-3E4547EBD503
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851852-74CB4FAF-6E69-4762-A30E-3E4547EBD503
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
P921
Q27851852-74CB4FAF-6E69-4762-A30E-3E4547EBD503
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851852-74CB4FAF-6E69-4762-A30E-3E4547EBD503
rank
NormalRank
type
BestRank
Statement
P921
phase I clinical trial